Literature DB >> 24003289

Agminated acquired melanocytic nevi of the common and dysplastic type.

Yoon Jung Choi1, Hei Sung Kim, Jun Young Lee, Hyung Ok Kim, Young Min Park.   

Abstract

Entities:  

Year:  2013        PMID: 24003289      PMCID: PMC3756211          DOI: 10.5021/ad.2013.25.3.380

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


× No keyword cloud information.
  8 in total

1.  A case of malignant melanoma arising from an acquired agminated melanocytic naevus.

Authors:  Maria Teresa Corradin; Mauro Alaibac; Anna Belloni Fortina
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

Review 2.  Dysplastic naevi: an update.

Authors:  David E Elder
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

Review 3.  Agminated atypical (dysplastic) nevi: case report and review of the literature.

Authors:  A A Marghoob; R Blum; R Nossa; K J Busam; D Sachs; A Halpern
Journal:  Arch Dermatol       Date:  2001-07

Review 4.  Agminated Spitz nevi: report of a child with a unique dermatomal distribution.

Authors:  M A Glasgow; Edward L Lain; Jay M Kincannon
Journal:  Pediatr Dermatol       Date:  2005 Nov-Dec       Impact factor: 1.588

5.  Agminated acquired melanocytic nevi of the common and dysplastic type.

Authors:  Jennifer W Bragg; Lucinda Swindle; Allan C Halpern; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2005-01       Impact factor: 11.527

6.  Quadrant distribution of dysplastic nevus syndrome.

Authors:  W Sterry; E Christophers
Journal:  Arch Dermatol       Date:  1988-06

7.  Unilateral dysplastic nevi associated with malignant melanoma.

Authors:  N Misago; M Takahashi; H Kohda
Journal:  J Dermatol       Date:  1991-11       Impact factor: 4.005

Review 8.  Agminated lentiginosis: case report and review of the literature.

Authors:  G Micali; M R Nasca; D Innocenzi; D Lembo
Journal:  Pediatr Dermatol       Date:  1994-09       Impact factor: 1.588

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.